Cancer Symptoms
Cancer Treatment
Cancer Therapy
Cancer Insurance
Pancreas Cancer
Metastatic Cancer
Cancer Types
Symptoms
Oncology
Life Expectancy
Chemotherapy
Cancer Symbol
Cancer Surgery
Cancer Doctor
Cancer Organizations
Cancer Disease
 
 
 
home About Us Contact Us Site Map
 

Cancer Lung

Overall, the most common symptoms of pancreatic adenocarcinoma include loss of appetite - of - and underweight, and irritation in the stomach and nausea. As these are fairly non-specific symptoms, and there is often a delay in reaching the final diagnosis. The most common physical sign of pancreatic cancer is jaundice, with or without associated with itching. Prior to medical evaluation often requires a high index of suspicion by the patient or by working in the medical field.

Pancreatic cancer is currently the fifth most common form of cancer in the United States and is diagnosed in around 40,000 Americans each year. In most cases the disease has an extremely poor survival outcome. Just 1 in 20 people diagnosed with pancreatic cancer will still be alive after five years. There are several risk factors that are known to affect an individual's probability of developing pancreatic cancer. While some of these cannot be changed, several can be influenced by sensible lifestyle and diet modifications.

Pancreatic cancer begins in the tissues of your pancreas, a large organ that lies horizontally behind the lower part of the stomach. Pancreatic cancer occurs most commonly in men between the ages of 35 and 70, it is the fourth most common cause of cancer mortality (behind lung cancer, colorectal cancer and breast cancer). Pancreatic cancer is usually an adenocarcinoma and it usually arises from the pancreatic duct cells which make up the major part of the pancreas.

The pancreas is a gland organ in the digestive and endocrine system. It produces several important hormones, including insulin, glucagon, and somatostatin as well as secretes pancreatic juice containing digestive enzymes. It is a very important organ dealing with digestion and hormone production but unfortunately also vulnerable to many infections including pancreatic cancer.

Phase I pancreatic cancer HSP trials in 1997, showed promising results despite some set-backs. HSP or heat-shock proteins are the caretakers of all protein and amino acid (peptide) sequences in the cell. If amino acid sequences and protein folding is out of place the heat-shock proteins fix the problem or have it removed from the cell. HSP assist in removing the foreign amino acid fragments from the cell to the immune system where T-cells decode the protein fragments. T-cells then rid the body of the unfamiliar peptides. Concerns from the previous pancreatic cancer HSP trial has been corrected and a Phase II pancreatic cancer HSP trial is currently underway.

Health Resources 1 Health Resources 2 Health Resources 3 Health Resources 4